Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences has informed shareholders about a six-month special window opened by SEBI (from July 7, 2025 to January 6, 2026) for re-lodging physical share transfer requests that were rejected, returned, or not processed before the April 1, 2019 deadline. During this window, any re-lodged securities will be issued only in demat mode after due process. The company also reminded shareholders holding physical shares that furnishing PAN, KYC, and nomination details remains mandatory, using forms ISR-1, SH-13, and SH-14 available on the company's website. Shareholders can reach out to the company or its RTA, Bigshare Services Pvt Ltd, for any queries.
This is a routine regulatory compliance communication with no direct impact on share price or business operations. Shareholders holding old physical share certificates that were stuck in rejected transfers before April 2019 now have a fresh chance to get them transferred and converted into demat form.